Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the RIETE Registry
By Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Jaime Luis Blasco Hernandez, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López Miguel, Manuel Monreal, and Cihan Ay
— On behalf of the RIETE Investigators
• The VTE-PREDICT score was designed to estimate recurrence and bleeding risks after acute VTE, but required validation in real-world populations.
• In 17 850 patients (median age 67 years; 64% with PE) from the RIETE registry, the model’s performance was tested for outcomes over 1–5 years under varied anticoagulant regimens.
• The score showed good discrimination for recurrence (c = 0.70–0.73) and moderate for bleeding (c = 0.65–0.67) but underestimated recurrence and overestimated bleeding in high-risk patients. Calibration refinement may enhance its clinical utility.”
Read the full article in JTH.
Article: External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmbὀlica Registry
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Luis Hernández-Blasco, Inés Jou, Juan José López-Núñez, Ángeles Fidalgo, Patricia López-Miguel, Manuel Monreal, Cihan Ay
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry